Nominees for best AbbVie blunder in the last 10 years are…

Quote

anonymous said:
Why? Why not the entire R&D due diligence team? Why not the AbbVie incompetent R&D leaders who devalued and eventually lost the CNS experts they acquired from Allergan who are responsible for their current commercial pipeline? Why not the decision makers who allow R&D to continue to fester in mediocrity (at best). Why not the legacy Allergan leaders who knew the space and the teams at other companies and didn’t advocate for say Karuna? Pretty sure a few people knew the former CEO and his track record in CNS.

ND is trying to fill these gaps but he cant do it alone. It’s a Phase 2 failure. This lies at the feet of R&D and a few commercial leaders who should have led.
Click to expand...
I already shit on this company's stupid botox play.
 
















anonymous said:
Why? Why not the entire R&D due diligence team? Why not the AbbVie incompetent R&D leaders who devalued and eventually lost the CNS experts they acquired from Allergan who are responsible for their current commercial pipeline? Why not the decision makers who allow R&D to continue to fester in mediocrity (at best). Why not the legacy Allergan leaders who knew the space and the teams at other companies and didn’t advocate for say Karuna? Pretty sure a few people knew the former CEO and his track record in CNS.

ND is trying to fill these gaps but he cant do it alone. It’s a Phase 2 failure. This lies at the feet of R&D and a few commercial leaders who should have led.
Click to expand...
Wow! Strange. Didn't ND get a fat bonus check along with his cronies for an M&A delivered.... same team should be held accountable too..all those folks in the CBSO...
 








anonymous said:
Why? Why not the entire R&D due diligence team? Why not the AbbVie incompetent R&D leaders who devalued and eventually lost the CNS experts they acquired from Allergan who are responsible for their current commercial pipeline? Why not the decision makers who allow R&D to continue to fester in mediocrity (at best). Why not the legacy Allergan leaders who knew the space and the teams at other companies and didn’t advocate for say Karuna? Pretty sure a few people knew the former CEO and his track record in CNS.

ND is trying to fill these gaps but he cant do it alone. It’s a Phase 2 failure. This lies at the feet of R&D and a few commercial leaders who should have led.
Click to expand...
Whoever received the credit for the M&A should be held accountable when it went south. Due diligence team did not get a fat check. Thank you.
 








































anonymous said:
awwww...did the iddy biddy gwade 17 genius have someting to say? You are irrelevant in everything you do
Click to expand...
Hey man. Not nice at all. You an 18 or something like that? Probably a manager looking in here to find people
To fire. So sad that managers have so little to do. Thank your reps for making you money.
 








































Top Bottom
Back
Quote